Foxhollow Technologies Report issue

For profit Phase 1
Founded: Redwood City CA United States (1996)
Status: Acquired by ev3 (2007) → now Medtronic (2014)

Organization Overview

First Clinical Trial
2005
NCT00720577
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

FoxHollow Technologies

Active Ingredients

Drugs in Phase 1 Trials (4)

losartan (cozaar) (1 trial)

mk0736 (1 trial)

pioglitazone (actos) (1 trial)

simvastatin (zocor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Peripheral Arterial Disease (Phase 1)

Peripheral Vascular Diseases (Phase 1)

Vascular Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 4